Sainati S[au] - Search Results

Year	Number of Results
1978	1
1982	1
1983	1
1991	1
1995	2
1997	1
1998	1
1999	1
2003	1
2005	1
2006	2
2007	1
2008	1
2009	1
2010	1
2015	1
2020	1
2022	0

1

Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria.

Freeman R, Gewandter JS, Faber CG, Gibbons C, Haroutounian S, Lauria G, Levine T, Malik RA, Singleton JR, Smith AG, Bell J, Dworkin RH, Feldman E, Herrmann DN, Hoke A, Kolb N, Mansikka H, Oaklander AL, Peltier A, Polydefkis M, Ritt E, Russell JW, Sainati S, Steiner D, Treister R, Üçeyler N. Freeman R, et al. Among authors: sainati s. Neurology. 2020 Dec 1;95(22):1005-1014. doi: 10.1212/WNL.0000000000010988. Epub 2020 Oct 14. Neurology. 2020. PMID: 33055271 Free PMC article. Review.

2

Pentoxifylline and diabetic neuropathy.

Sainati SM. Sainati SM. Diabetes Care. 1991 Oct;14(10):930. doi: 10.2337/diacare.14.10.930a. Diabetes Care. 1991. PMID: 1812883 Clinical Trial. No abstract available.

3

The effects of ramelteon in a first-night model of transient insomnia.

Zammit G, Schwartz H, Roth T, Wang-Weigand S, Sainati S, Zhang J. Zammit G, et al. Among authors: sainati s. Sleep Med. 2009 Jan;10(1):55-9. doi: 10.1016/j.sleep.2008.04.010. Epub 2008 Aug 8. Sleep Med. 2009. PMID: 18691937 Clinical Trial.

4

Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia.

Murck H, Laughren T, Lamers F, Picard R, Walther S, Goff D, Sainati S. Murck H, et al. Among authors: sainati s. Innov Clin Neurosci. 2015 Mar-Apr;12(3-4):26S-40S. Innov Clin Neurosci. 2015. PMID: 25977838 Free PMC article.

5

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.

Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N, Demeyer I, Sainati S, Amlot N, Cao C, Ii M, Matsuda H, Mouri K, Cohen J. Rice TW, et al. Among authors: sainati s. Crit Care Med. 2010 Aug;38(8):1685-94. doi: 10.1097/CCM.0b013e3181e7c5c9. Crit Care Med. 2010. PMID: 20562702 Clinical Trial.

6

Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.

Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, Roth T. Zammit G, et al. Among authors: sainati s. J Clin Sleep Med. 2007 Aug 15;3(5):495-504. J Clin Sleep Med. 2007. PMID: 17803013 Free PMC article. Clinical Trial.

7

Valdecoxib, a COX-2-specific inhibitor, does not affect cardiac repolarization.

Sarapa N, Britto MR, Cotton B, Cox SR, Francom SF, Jin N, Polasek ED, Sainati SM, Crosby-Sessoms SL, Fleishaker JC. Sarapa N, et al. Among authors: sainati sm. J Clin Pharmacol. 2003 Sep;43(9):974-82. doi: 10.1177/0091270003257220. J Clin Pharmacol. 2003. PMID: 12971029 Clinical Trial.

8

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P. Roth T, et al. Among authors: sainati s. Sleep Med. 2006 Jun;7(4):312-8. doi: 10.1016/j.sleep.2006.01.003. Epub 2006 May 18. Sleep Med. 2006. PMID: 16709464 Clinical Trial.

9

Coadministration of short-term zolpidem with sertraline in healthy women.

Allard S, Sainati SM, Roth-Schechter BF. Allard S, et al. Among authors: sainati sm. J Clin Pharmacol. 1999 Feb;39(2):184-91. doi: 10.1177/00912709922007624. J Clin Pharmacol. 1999. PMID: 11563412 Clinical Trial.

10

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.

Erman M, Seiden D, Zammit G, Sainati S, Zhang J. Erman M, et al. Among authors: sainati s. Sleep Med. 2006 Jan;7(1):17-24. doi: 10.1016/j.sleep.2005.09.004. Epub 2005 Nov 23. Sleep Med. 2006. PMID: 16309958 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results